Franklin Templeton Files Schedule 13G/A for Contineum Therapeutics
Franklin Templeton filed a Schedule 13G/A for Contineum Therapeutics.
Related stories
Microsoft shares reverse course, down 1.3%
M impact | EQUITY | Oct 29, 2026, 03:05 PM UTC
SHL Finance Q3 net profit SAR 11.575 million
M impact | EQUITY | Oct 29, 2026, 03:04 PM UTC
Forbright Inc Reports Quarterly Results for Quarter Ended September 30
M impact | EQUITY | Oct 29, 2026, 03:04 PM UTC
BW Energy Postpones MaBoMo Phase II
BW Energy postponed MaBoMo Phase II.
M impact | EQUITY | Oct 29, 2026, 03:04 PM UTC
SPIMACO Reports Q3 Net Loss of SAR 33.3 Million
M impact | EQUITY | Oct 29, 2026, 03:04 PM UTC
Lowe's Companies Shares Hit 7-week High
Lowe's Companies shares increased to 204.54 USD, the highest since September 2026. Over the past 4 weeks, Lowe's Companies gained 10.84%, and in the last 12 months, it decreased 14
L impact | EQUITY | Oct 29, 2026, 03:03 PM UTC